Affiliation:
1. Department of Laboratory Medicine, University of California San Francisco, San Francisco, CA 94107, USA
2. San Francisco General Hospital, San Francisco, CA 94110, USA
Abstract
Background: In clinical laboratories, a large proportion of the toxicology workload is drug confirmations. Our GC–MS method for opioid confirmation detects total codeine, morphine, hydrocodone, hydromorphone, oxycodone and oxymorphone. The objective of this study was to develop a LC–MS/MS assay measuring the above drugs and glucuronide metabolites. In addition, to determine if measuring free drug only would lead to false negative results. Results: In 85 patient urines, 43% were positive for morphine glucuronide, but not morphine, 48% were positive for hydromorphone glucuronide, but not hydromorphone, 33% were positive for codeine glucuronide, but not codeine, and 44% were positive for oxymorphone glucuronide, but not oxymorphone. Conclusion: We developed an LC–MS/MS assay capable of detecting codeine, morphine, hydrocodone, hydromorphone, oxycodone, oxymorphone and glucuronide metabolites. Detection of free drug only led to false negative confirmations.
Subject
Medical Laboratory Technology,Clinical Biochemistry,General Pharmacology, Toxicology and Pharmaceutics,General Medicine,Analytical Chemistry
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献